410772

Sigma-Aldrich

3-Oxo-1-indancarboxylic acid

98%

Empirical Formula (Hill Notation):
C10H8O3
CAS Number:
Molecular Weight:
176.17
MDL number:
PubChem Substance ID:
NACRES:
NA.22
Pricing and availability is not currently available.

assay

98%

mp

111-113 °C (lit.)

SMILES string

OC(=O)C1CC(=O)c2ccccc12

InChI

1S/C10H8O3/c11-9-5-8(10(12)13)6-3-1-2-4-7(6)9/h1-4,8H,5H2,(H,12,13)

InChI key

HXLJFMRZKCSTQD-UHFFFAOYSA-N

Related Categories

General description

3-Oxo-1-indancarboxylic acid participates in the synthesis of 3-hydroxymethyl-1-indanol (±). Enantiomeric separation of 3-oxo-1-indancarboxylic acid on liquid chromatography chiral stationary phases (CSPs) by supercritical fluid chromatography (SFC) has been reported. Separation of 3-oxo-1-indancarboxylic acid enantiomers using a new immobilized polysaccharide chiral stationary phase, CHIRALPAK IA with hexane has been described.

Packaging

1, 10 g in glass bottle

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves

RIDADR

NONH for all modes of transport

WGK Germany

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificate of Analysis
Certificate of Origin
Kinetic resolution of 3-hydroxymethylbenzocycloalkanols by selective asymmetric hydrogen-transfer oxidation.
Caro Y, et al.
Tetrahedron Asymmetry, 14(23), 3689-3696 (2003)
Super/subcritical fluid chromatography separations with four synthetic polymeric chiral stationary phases.
Han X, et al.
Chromatographia, 65(7-8), 381-400 (2007)
Extending the Range of Solvents for Chiral Analysis Using a New Immobilized Polysaccharide Chiral Stationary Phase, CHIRALPAK IA.
Cox GB and Amoss CW.
LCGC North America, 22(2), 32-32 (2004)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.